Clinical trial
Study to Investigate the Effect of Aprotinin of Transfusion Requirements in…
NCT00306137 · Bayer, Industry · Terminated
Key facts
| NCT number | NCT00306137 |
|---|---|
| Title | Study to Investigate the Effect of Aprotinin of Transfusion Requirements in Patients Undergoing Surgical Procedures for Lung or Esophageal Cancer |
| Official title | A Multi-Center, Randomized, Double-Blind, Placebo-Controlled, Parallel Design, 2-Arm Study to Investigate the Effect of Aprotinin on Transfusion Requirements in Patients Undergoing Surgical Procedures for Lung Cancer or Esophageal Cancer |
| Lead sponsor | Bayer, Industry |
| Status | Terminated |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Blood Loss, Surgical |
| Intervention type | Drug |
| Interventions | Trasylol (Aprotinin, BAYA0128), Placebo |
| Enrollment | 104 |
| Start date | Dec 1, 2005 |
| Completion | Mar 1, 2007 |
| First posted | Mar 23, 2006 |
| Last update posted | Dec 9, 2014 |
| Countries | Australia, Austria, Belgium, Canada, Denmark, France, Germany, Spain, United Kingdom, United States |
At a glance
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: